Exchange confirms compensation amount for SCM Life Science's 'mistake in removing management items'
⚡ Quick Summary
(Seoul = Yonhap News) Reporter Hwang Cheol-hwan = Investment that suffered losses due to the Korea Exchange's mistake in re-designating SCM Life Science [298060] (currently Poongjeon Pharmaceutical [298060]) as a managed stock...